Building a More Proactive Future for Breast Cancer Care: AxelleMD Joins Breast Society of Ghana at Its Annual General & Scientific Meeting
AxelleMD joined clinicians, pharmaceutical industry leaders, government agencies, investors, patients, breast cancer survivors and community leaders, at the Breast Society of Ghana’s Annual General & Scientific Meeting, held on 20–21 August 2026 at Fiesta Royale Hotel.
Held under the theme “Bridging the Breast Cancer Care Gap for Everyone, Every Step, Everywhere,” the meeting provided an important platform for stakeholders across the breast cancer ecosystem to examine how Ghana can strengthen the patient journey and improve access to quality care.
Our CEO, Sam Nii Adjaidoo presented the platform’s vision of moving healthcare from reactive engagement towards more proactive systems that help people understand and navigate their health journeys. Most patients, he noted, only engage with healthcare once something is already wrong.
The AxelleMD platform seeks to address this very issue. Through accessible, visual and engaging health education, the platform helps patients and caregivers better understand their condition, prepare for conversations with their healthcare providers, and navigate the different stages of their care journey. The objective is to ensure that patients arrive at each interaction better informed and more prepared to participate in their care.
This reflects AxelleMD’s broader identity as a health intelligence and clinical decision-support platform: patient education is not simply about information delivery, but about generating insights — from how patients engage, what they understand, and where they need more support — that can, in turn, be used to serve both patients and clinicians better. For clinicians, this informed-patient approach can be particularly valuable in an environment where consultation time is limited and patient volumes are high.
The conversation, however, extends well beyond the consulting room. Patients and survivors bring lived experience, while caregivers offer a critical perspective on the realities of supporting someone through cancer. Pharmaceutical companies and government agencies have important roles in strengthening access and health systems, and investors can help scale solutions with potential for population-level impact. Community leaders are essential to reaching people where health decisions and conversations actually happen.
At a health-system level, preventive education and earlier engagement can also help governments reduce the cost of healthcare over time by supporting healthier populations, reducing avoidable complications and easing pressure on already stretched health systems.
At our exhibition stand, members of the Society had the opportunity to experience the platform firsthand and explore how it could support patient education and navigation breast care.
We appreciates the Breast Society of Ghana for the opportunity to share this work with the wider breast care community, and for convening a platform where proactive, patient-centred approaches to care could be discussed alongside the perspectives of clinicians, survivors and stakeholders across the ecosystem.
The engagement reinforced a fundamental principle behind AxelleMD: closing the care gap requires more than clinical intervention. It requires patients who understand, caregivers who are equipped, clinicians who are supported, and institutions and communities that are connected to the care journey.
Closing the breast cancer care gap is, ultimately, a collective undertaking; one that depends on all stakeholders working together, each contributing what they are best placed to offer. It is through this kind of collaboration that health education and navigation tools, and the systems built around them, are able to reach beyond any single hospital or clinic and into the communities and care settings where they are needed most.
